Leuthold Group’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-58,843
Closed -$1.45M 258
2016
Q2
$1.45M Buy
58,843
+5,111
+10% +$127K 0.15% 156
2016
Q1
$1.19M Buy
53,732
+1,067
+2% +$28.4K 0.13% 157
2015
Q4
$1.84M Buy
52,665
+2,368
+5% +$74.2K 0.19% 137
2015
Q3
$1.43M Sell
50,297
-3,214
-6% -$108K 0.15% 148
2015
Q2
$1.78M Buy
+53,511
New +$1.64M 0.17% 160
2014
Q3
Sell
-151,303
Closed -$4.33M 225
2014
Q2
$4.33M Sell
151,303
-113
-0.1% -$3.14K 0.37% 95
2014
Q1
$4.24M Sell
151,416
-1,750
-1% -$43K 0.38% 96
2013
Q4
$3.29M Buy
153,166
+26,549
+21% +$483K 0.29% 108
2013
Q3
$1.68M Buy
+126,617
New +$1.71M 0.16% 169

Other funds holding PMC

Leuthold Group's PMC Position: Q3 2016 in Review

Leuthold Group sold out of PharMerica Corporation (PMC) in Q3 2016, closing a stake of 58,843 shares — an estimated $1.45M sold.

Leuthold Group first reported a position in PMC in Q3 2013 and held it in 9 quarters. The position peaked at $4.33M in Q2 2014. 172 funds tracked by Wall St. Rank hold PMC as of Q3 2016.

  • Leuthold Group reported no remaining PharMerica Corporation position as of Q3 2016 after selling out during the quarter.
  • Leuthold Group sold 58,843 PharMerica Corporation shares in Q3 2016, an estimated $1.45M.
  • Leuthold Group first reported a position in PharMerica Corporation in Q3 2013 and held it in 9 quarters.
  • Leuthold Group's PharMerica Corporation position peaked at $4.33M in Q2 2014.
  • 172 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2016.

Based on Leuthold Group's 13F filing for Q3 2016, filed 14 Nov 2016.